Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Echo Therapeutics Inc.
DescriptionTopical AzoneTS reformulation of triamcinolone acetonide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDermatosis
Indication DetailsTreat corticosteroid-responsive dermatoses
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today